Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 100 101 102 103 104 105 106 107 108 109 Next Last

  • Gugliucci, A, Caccavello, R., & Kimura, S. (2012).  Soluble receptor for advanced glycation end correlates negatively with BMI in patients with end-stage renal disease undergoing hemodialysis: A mechanism for the obesity paradox? Journal of the American Osteopathic Association, 112(8), 539.

  • Gugliucci, A., Caccavello, R., Kotani, K., & Kimura, S. (2014). Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein. Redox Report, 19(4), 154-160. doi:10.1179/1351000214Y.0000000084

    		•

  • Gugliucci, A., Caccavello, R., Kotani, K., Sakane, N., & Kimura, S. (2013). Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: A practical zymogram method to assess HDL function. Clinica Chimica Acta, 415, 162-168.  doi:10.1016/j.cca.2012.10.044

    		•

  • Gugliucci, A., Caccavello, R., Nassar, H., Abu Ahmad, W., Sinnreich, R., & Kark, J. D. (2014). Lower PON1 lactonase activity explains part of the increased cardiovascular risk among Arab versus Jewish residents of Jerusalem. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.505

    		•

  • Gugliucci, A., Caccavello, R., Nassar, H., Abu Ahmad, W., Sinnreich, R., & Kark, J. D. (2015). Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes. Clinica Chimica Acta, 445, 41-47. doi:10.1016/j.cca.2015.03.012

    		•

  • Gugliucci, A., Hermo, R., Tsuji, M., & Kimura, S. (2006). Lower serum paraoxonase-1 activity in type 2 diabetic patients correlates with nitrated apolipoprotein A-I levels. Clinica Chimica Acta, 368(1-2), 201-202. doi:10.1016/j.cca.2006.01.011

    		•

  • Gugliucci, A., Kimura, S., & Kinugasa, E. (2014). HDL remodeling during hemodialysis is associated with activation of paraoxonase 1. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.506

    		•

  • Gugliucci, A., Kimura, S., Menini, T., Hermo, R., & Numaguchi, M. (2010). Serum aspirin esterase activity in cord blood and in adults. Journal of Pediatric Biochemistry, 1(1), 7-10. doi:10.3233/JPB-2010-0005

    		•

  • Gugliucci, A., Kimura, S., Menini, T., Taing, J., & Numaguchi, M. (2010). Serum low molecular weight fluorescent AGEs are higher in neonates than in adults: Role of kidney metabolism. In M. C. Thomas, & J. Forbes (Eds.), The Maillard reaction: Interface between aging, nutrition, and metabolism (pp. 125-132). La Vergne, TN: Ingram. This material can be found here.

  • Gugliucci, A., Kinugasa, E., Kotani, K., Caccavello, R., & Kimura, S. (2011). Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. Clinical Chemistry and Laboratory Medicine, 49(1), 61-67. doi:10.1515/CCLM.2011.004

    		•

  • Gugliucci, A., Kinugasa, E., Ogata, H., Caccavello, R., & Kimura, S. (2014). Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL. Clinica Chimica Acta, 430, 9-14.  doi:10.1016/j.cca.2013.12.027

    		•

  • Gugliucci, A., Kotani, K., & Caccavello, R. (2011). Influence of ezetimbe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients. Journal of the American Osteopathic Association, 111(8), 494.

  • Gugliucci, A., Kotani, K., & Caccavello, R. (2011). Influence of physical activity intervention on circulating soluble receptor for advanced glycation end products in elderly subjects. Journal of the American Osteopathic Association, 111(8), 495.

  • Gugliucci, A, Kotani, K., & Caccavello, R. (2012). Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in healthy participants. Journal of the American Osteopathic Association, 112(8), 538.

  • Gugliucci, A., Kotani, K., & Kimura, S. (2012). Paraoxonase 1 in chronic kidney failure. Journal of Lipids, [Article 726048]. doi:10.1155/2012/726048

    		•

  • Gugliucci, A, Kotani, K, Ishibashi, I, Caccavello, R, & Miyamoto, M. (2011). Influence of a short-term change in glucose and cholesterol concentrations on aspirin esterase activity in patients with type 2 diabetes mellitus [Supplemental material]. Diabetes, 60, A144. doi:10.2337/db11-478-715

    		•

  • Gugliucci, A., Kotani, K., Kimura, S., & Menini, T. (2014). Small dense LDL carries active paraoxonase 1. Atherosclerosis, 235(2), e163-e164. doi:10.1016/j.atherosclerosis.2014.05.470

    		•

  • Gugliucci, A., Kotani, K., Kinugasa, E., Hermo, R., Caccavello, R., & Kimura, S. (2010). Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysis. Annals of Clinical Biochemistry, 47(6), 559-563. This material can be found here.

  • Gugliucci, A., Kotani, K., Taing, J., Matsuoka, Y., Sano, Y., Yoshimura, M., . . . Sakane, N. (2009). Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Annals of Nutrition and Metabolism, 54(3), 197-201. doi:10.1159/000217817

    		•

  • Gugliucci, A., Lunceford, N., Kinugasa, E., Ogata, H., Schulze, J., & Kimura, S. (2007). Acrolein inactivates paraoxonase 1: Changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clinica Chimica Acta, 384(1-2), 105-112. doi:10.1016/j.cca.2007.06.012

    		•

  • Gugliucci, A., Lustig, R. H., Caccavello, R., Erkin-Cakmak, A., Noworolski, S. M., Mulligan, K., . . . Schwarz, J. M. (2016). Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis, 253, 171-177. doi:10.1016/j.atherosclerosis.2016.06.048

    		•

  • Gugliucci, A., Mehlhaff, K., Kinugasa, E., Ogata, H., Hermo, R., John Schulze, J., & Kimura, S. (2007). Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearance. Clinica Chimica Acta, 377(1-2), 213-220. doi:10.1016/j.cca.2006.09.028

    		•

  • Gugliucci, A., Menini, T., Ikeda, H., & Kimura, S. (2015). Changes in HDL function in acute inflammation as revealed by optimized zymogram to study PON1 in subclasses: Pilot study. Proceedings: 17th International Symposium on Atherosclerosis, Amsterdam, June 2015 [Article 246].

  • Gugliucci, A., Menini, T., Kotani, K., & Caccavello, R. (2011). Serum paraoxonase esterase and lactonase activities correlate with intermediate size HDL particles. Journal of the American Osteopathic Association, 111(8), 495.

  • Gugliucci, A., Numaguchi, M., Caccavello, R., & Kimura, S. (2014). Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood. Redox Report, 19(3), 124-132. doi:10.1179/1351000213Y.0000000081

    		•
First Prev 100 101 102 103 104 105 106 107 108 109 Next Last